Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$32.49
0.060.19%
al cierre: -
$32.49
0.000.00%
After hour: Oct 31, 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Imax Corp ha un obiettivo di prezzo di consenso pari a $31.5, stabilito in base alle ultime valutazioni degli analisti di 14. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barrington Research, Wells Fargo y JP Morgan il octubre 24, 2025. Con un obiettivo di prezzo medio di $36.33 tra le Barrington Research, Wells Fargo y JP Morgan, c'è un implicito 11.83% upside per Imax Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barrington Research
Wells Fargo
JP Morgan
Rosenblatt
Roth Capital
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Imax
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/24/2025 | 13.88% | Barrington Research | $37 → $37 | Maintains | Outperform | |||
10/24/2025 | 23.11% | Wells Fargo | $34 → $40 | Maintains | Overweight | |||
10/24/2025 | -1.51% | JP Morgan | $31 → $32 | Maintains | Neutral | |||
10/24/2025 | 29.27% | Rosenblatt | $42 → $42 | Maintains | Buy | |||
10/23/2025 | 13.88% | Barrington Research | $37 → $37 | Maintains | Outperform | |||
10/14/2025 | 23.11% | Roth Capital | $36 → $40 | Maintains | Buy | |||
10/09/2025 | 29.27% | Rosenblatt | $37 → $42 | Maintains | Buy | |||
10/09/2025 | -4.59% | JP Morgan | $28 → $31 | Maintains | Neutral | |||
09/23/2025 | 13.88% | Barrington Research | $37 → $37 | Maintains | Outperform | |||
09/22/2025 | 20.04% | Wedbush | $35 → $39 | Maintains | Outperform | |||
09/19/2025 | 13.88% | Barrington Research | $32 → $37 | Maintains | Outperform | |||
07/25/2025 | 4.65% | Wells Fargo | $30 → $34 | Maintains | Overweight | |||
07/25/2025 | 7.73% | Wedbush | $34 → $35 | Maintains | Outperform | |||
07/25/2025 | -1.51% | Benchmark | $30 → $32 | Maintains | Buy | |||
07/25/2025 | 13.88% | Rosenblatt | $35 → $37 | Maintains | Buy | |||
07/24/2025 | -1.51% | Barrington Research | $32 → $32 | Maintains | Outperform | |||
07/11/2025 | 7.73% | Rosenblatt | $35 → $35 | Maintains | Buy | |||
07/09/2025 | 10.8% | Roth Capital | $36 → $36 | Reiterates | Buy → Buy | |||
06/16/2025 | 7.73% | Rosenblatt | $35 → $35 | Maintains | Buy | |||
06/13/2025 | 10.8% | Roth Capital | $32 → $36 | Maintains | Buy | |||
04/25/2025 | -1.51% | Macquarie | $30 → $32 | Maintains | Outperform | |||
04/24/2025 | -1.51% | Barrington Research | $32 → $32 | Maintains | Outperform | |||
04/24/2025 | -7.66% | Wells Fargo | $32 → $30 | Maintains | Overweight | |||
04/24/2025 | 7.73% | Rosenblatt | $35 → $35 | Maintains | Buy | |||
04/11/2025 | -19.98% | JP Morgan | $27 → $26 | Maintains | Neutral | |||
04/10/2025 | -7.66% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
04/10/2025 | 7.73% | Rosenblatt | $35 → $35 | Maintains | Buy | |||
02/21/2025 | -16.9% | JP Morgan | $25 → $27 | Maintains | Neutral | |||
02/20/2025 | -7.66% | Macquarie | $28 → $30 | Maintains | Outperform | |||
02/20/2025 | -1.51% | Barrington Research | $30 → $32 | Maintains | Outperform | |||
02/20/2025 | -7.66% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
02/20/2025 | -1.51% | Wells Fargo | $26 → $32 | Maintains | Overweight | |||
02/20/2025 | 7.73% | Rosenblatt | $28 → $35 | Maintains | Buy | |||
02/12/2025 | -1.51% | Wedbush | $32 → $32 | Reiterates | Outperform → Outperform | |||
01/30/2025 | -23.05% | JP Morgan | $21 → $25 | Maintains | Neutral | |||
01/17/2025 | -7.66% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
01/16/2025 | -13.82% | Rosenblatt | $28 → $28 | Maintains | Buy | |||
01/13/2025 | -7.66% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
01/10/2025 | -7.66% | Barrington Research | $30 → $30 | Maintains | Outperform | |||
01/10/2025 | -7.66% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
12/13/2024 | -7.66% | Benchmark | $27 → $30 | Maintains | Buy | |||
11/27/2024 | -1.51% | Wedbush | $26 → $32 | Maintains | Outperform | |||
11/01/2024 | -16.9% | Macquarie | $26 → $27 | Maintains | Outperform | |||
11/01/2024 | -13.82% | Barrington Research | $24 → $28 | Maintains | Outperform | |||
10/31/2024 | -13.82% | Roth MKM | $27 → $28 | Maintains | Buy | |||
10/31/2024 | -26.13% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
10/31/2024 | -13.82% | Rosenblatt | $28 → $28 | Maintains | Buy | |||
10/14/2024 | -35.36% | JP Morgan | $20 → $21 | Maintains | Neutral | |||
10/10/2024 | -16.9% | Roth MKM | $27 → $27 | Maintains | Buy | |||
10/04/2024 | -13.82% | Rosenblatt | $28 → $28 | Maintains | Buy | |||
09/25/2024 | -26.13% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
09/03/2024 | -19.98% | Wedbush | $24 → $26 | Maintains | Outperform | |||
07/26/2024 | -16.9% | Roth MKM | $23 → $27 | Maintains | Buy | |||
07/26/2024 | -13.82% | Rosenblatt | $25 → $28 | Maintains | Buy | |||
07/26/2024 | -26.13% | Wedbush | $22 → $24 | Maintains | Outperform | |||
07/26/2024 | -23.05% | Barrington Research | $25 → $25 | Maintains | Outperform | |||
07/26/2024 | -19.98% | Macquarie | $24 → $26 | Maintains | Outperform | |||
07/24/2024 | -29.21% | Seaport Global | → $23 | Initiates | → Buy | |||
07/18/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
07/18/2024 | -29.21% | Roth MKM | $22 → $23 | Maintains | Buy | |||
07/08/2024 | -7.66% | B. Riley Securities | $27 → $30 | Maintains | Buy | |||
06/20/2024 | -32.29% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
06/17/2024 | -23.05% | Rosenblatt | $25 → $25 | Maintains | Buy | |||
04/26/2024 | -32.29% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
04/26/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
04/25/2024 | -26.13% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
04/22/2024 | -26.13% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
04/18/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
04/16/2024 | -32.29% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
04/10/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
04/10/2024 | -32.29% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
03/04/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
03/04/2024 | -26.13% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | |||
02/28/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
02/28/2024 | -26.13% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | |||
02/23/2024 | -32.29% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | |||
02/13/2024 | -23.05% | Rosenblatt | $30 → $25 | Maintains | Buy | |||
02/06/2024 | -47.68% | JP Morgan | $20 → $17 | Maintains | Neutral | |||
01/18/2024 | -32.29% | Benchmark | $24 → $22 | Maintains | Buy | |||
01/11/2024 | -59.99% | Goldman Sachs | $15 → $13 | Maintains | Sell | |||
01/02/2024 | -35.36% | B. Riley Securities | $27 → $21 | Maintains | Buy | |||
12/05/2023 | -7.66% | Rosenblatt | → $30 | Reiterates | Buy → Buy | |||
10/10/2023 | -7.66% | Rosenblatt | → $30 | Reiterates | Buy → Buy | |||
10/09/2023 | -26.13% | Benchmark | $23 → $24 | Maintains | Buy | |||
08/25/2023 | -7.66% | Rosenblatt | $27 → $30 | Maintains | Buy | |||
08/18/2023 | -7.66% | Rosenblatt | $27 → $30 | Maintains | Buy | |||
07/28/2023 | -26.13% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | |||
07/27/2023 | -19.98% | Wedbush | → $26 | Reiterates | Outperform → Outperform | |||
07/27/2023 | -7.66% | Rosenblatt | $27 → $30 | Maintains | Buy | |||
07/20/2023 | -19.98% | Wedbush | → $26 | Reiterates | Outperform → Outperform | |||
07/13/2023 | -29.21% | Benchmark | → $23 | Reiterates | Buy → Buy | |||
07/13/2023 | -19.98% | Wedbush | → $26 | Reiterates | Outperform → Outperform | |||
07/13/2023 | -16.9% | Rosenblatt | → $27 | Reiterates | Buy → Buy | |||
07/12/2023 | -19.98% | Roth MKM | $26 → $26 | Reiterates | Buy → Buy | |||
05/02/2023 | -26.13% | Barrington Research | → $24 | Reiterates | → Outperform | |||
05/02/2023 | -29.21% | Benchmark | $22 → $23 | Maintains | Buy | |||
04/28/2023 | -16.9% | B. Riley Securities | $26 → $27 | Maintains | Buy | |||
04/28/2023 | -19.98% | Roth MKM | $24 → $26 | Maintains | Buy | |||
04/28/2023 | -23.05% | Wells Fargo | $22 → $25 | Maintains | Overweight | |||
04/28/2023 | -16.9% | Rosenblatt | $25 → $27 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Imax (IMAX)?
El último precio objetivo de Imax (NYSE:IMAX) fue comunicado por Barrington Research el octubre 24, 2025. La firma de analistas fijó un precio objetivo para $37.00 que espera IMAX a rise dentro de 12 meses (un posible 13.88% upside). 42 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Imax (IMAX)?
La última calificación de analistas para Imax (NYSE:IMAX) fue proporcionada por Barrington Research, y Imax mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Imax (IMAX)?
No hay última actualización para Imax
¿Cuándo fue la última revisión a la baja de Imax (IMAX)?
No hay una última revisión a la baja para Imax.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Imax (IMAX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Imax, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Imax se registró el octubre 24, 2025, por lo que la próxima calificación estará disponible en torno al octubre 24, 2026.
¿Es correcta la calificación de los analistas sobre Imax (IMAX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Imax (IMAX) fue un mantuvo con un precio objetivo de $37.00 a $37.00. El precio actual al que cotiza Imax (IMAX) es de $32.49, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.